Avior Wealth Management’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,901
Closed -$34.3K 1989
2024
Q4
$34.3K Hold
2,901
﹤0.01% 1271
2024
Q3
$33.5K Hold
2,901
﹤0.01% 1260
2024
Q2
$30.7K Hold
2,901
﹤0.01% 1250
2024
Q1
$30.6K Hold
2,901
﹤0.01% 1433
2023
Q4
$32.6K Hold
2,901
﹤0.01% 804
2023
Q3
$33.9K Hold
2,901
﹤0.01% 847
2023
Q2
$29.2K Buy
2,901
+353
+14% +$3.16K ﹤0.01% 866
2023
Q1
$18.8K Buy
+2,548
New +$21K ﹤0.01% 957

Other funds holding ROIV

Avior Wealth Management's ROIV Position: Q1 2025 in Review

Avior Wealth Management sold out of Roivant Sciences (ROIV) in Q1 2025, closing a stake of 2,901 shares — an estimated $34.3K sold.

Avior Wealth Management first reported a position in ROIV in Q1 2023 and held it in 8 quarters. The position peaked at $34.3K in Q4 2024. 312 funds tracked by Wall St. Rank hold ROIV as of Q1 2025.

  • Avior Wealth Management reported no remaining Roivant Sciences position as of Q1 2025 after selling out during the quarter.
  • Avior Wealth Management sold 2,901 Roivant Sciences shares in Q1 2025, an estimated $34.3K.
  • Avior Wealth Management first reported a position in Roivant Sciences in Q1 2023 and held it in 8 quarters.
  • Avior Wealth Management's Roivant Sciences position peaked at $34.3K in Q4 2024.
  • 312 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2025.

Based on Avior Wealth Management's 13F filing for Q1 2025, filed 21 Apr 2025.